22nd Century Group Cuts $1.5M Debt, Extends Loan Balance by Mark Eisenberg 26.06.2024 22nd Century Group cuts debt by $1.5M, aiming for financial stability and progress in tobacco harm reduction using advanced technology.
Philip Morris Halts Zyn.com Sales After D.C. Subpoena by Mark Eisenberg 18.06.2024 Philip Morris halts nationwide ZYN.com sales amid D.C. subpoena on flavored nicotine pouches. Investigation on compliance with 2022 flavor ban ...
Altria Group Dividends Forecast for the Year by Mark Eisenberg 25.04.2024 Altria Group distributed $6.8 billion in dividend payments in 2023, offering investors $0.98 per share quarterly payout.
2 S&P 500 Dividend Stocks With Yields Above 6% by Terry Bingman 24.04.2024 Altria Group, the company behind Marlboro cigarettes, could be a good long-term investment with yields above 6% and a history ...
Are Apps Turning Us Into Unpaid Lobbyists? by Lilu Anderson 31.03.2024 Google and its allies' lobbying efforts on Capitol Hill had limited success as the legislation they opposed was swiftly killed. ...
Investing in Philip Morris International: A Smoking-Hot Buy by Terry Bingman 31.03.2024 Global tobacco giant, Philip Morris International, has struggled in recent years but holds potential for growth with its IQOS and ...
22nd Century Group, Inc.: Financial Report Reveals Industry Challenges by Terry Bingman 28.03.2024 22nd Century Group, Inc. (XXII): A promising tobacco industry player with innovative plant science focus, solid financials & growth potential. ...
Amazon Replacing Walgreens on Dow: The Mystery Unveiled by Mark Eisenberg 22.02.2024 Next week, Amazon will join the Dow Jones Industrial Average, showcasing the index's reliance on innovation and longevity. Walmart's upcoming ...
Chicago Files Lawsuit Against Oil and Gas Companies for Climate Change by John Darbie 21.02.2024 The city of Chicago is suing oil and gas companies as well as a trade group over their role in ...
Incannex’s Breakthrough Chewing Gum Aids Smoking Cessation by Mark Eisenberg 16.02.2024 Incannex Healthcare makes breakthrough in smoking cessation drug program as FDA approves clinical trials for CannQuit-N chewing gum.